HLA-B*27 is associated with a more chronic and extensive disease course in male children and adolescents with enthesitis-related arthritis (ERA) and with a better response to anti-TNF treatment in ankylosing spondylitis [19, 20]. Here, TNF is linked to enthesitis-related juvenile idiopathic arthritis.